Cystatin C levels are associated with the prognosis of systolic heart failure patients

Archives of Cardiovascular Diseases

Volumn 104, Issue 11, 2011, Pages 565-571

  Gao, Changlu ^a   Zhong, Lihua ^a   Gao, Yanhui ^a   Li, Xueqi ^a   Zhang, Mingyu ^a   Wei, Shipeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cystatin C; Heart failure; High sensitivity C reactive protein; Homocysteine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYSTATIN C; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEART DEATH; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR AGENTS; CHINA; CYSTATIN C; DISEASE PROGRESSION; FEMALE; HEART FAILURE, SYSTOLIC; HEART TRANSPLANTATION; HOMOCYSTEINE; HOSPITALS, UNIVERSITY; HUMANS; INFLAMMATION MEDIATORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 82255192295     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.08.003     Document Type: Article

References (28)

1. J.T. Vilquin, and J.P. Marolleau Cell transplantation in heart failure management Med Sci (Paris) 20 2004 651 662
2. Z. Mallat, I. Philip, M. Lebret, D. Chatel, J. Maclouf, and A. Tedgui Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure Circulation 97 1998 1536 1539 (Pubitemid 28186180)
3. M.F. Hill, and P.K. Singal Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction Circulation 96 1997 2414 2420 (Pubitemid 27425850)
4. N. Suematsu, H. Tsutsui, and J. Wen Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes Circulation 107 2003 1418 1423 (Pubitemid 36350742)
5. P. Zhang, M. Hou, and Y. Li NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart Am J Physiol Heart Circ Physiol 296 2009 H840 H846
6. T. Tsutsui, T. Tsutamoto, and A. Wada Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure J Am Coll Cardiol 39 2002 957 962 (Pubitemid 34234116)
7. M. Valgimigli, E. Merli, and P. Malagutti Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction J Am Coll Cardiol 43 2004 2000 2008 (Pubitemid 38686793)
8. L. Agoston-Coldea, T. Mocan, M. Gatfosse, S. Lupu, and D.L. Dumitrascu Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction Cardiol J 18 2011 55 62
9. Y.T. Sia, N. Lapointe, and T.G. Parker Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat Circulation 105 2002 2549 2555 (Pubitemid 34568979)
10. K. Nakamura, K. Kusano, and Y. Nakamura Carvedilol decreases elevated oxidative stress in human failing myocardium Circulation 105 2002 2867 2871 (Pubitemid 34666100)
11. H. Tsutsui, T. Ide, and T. Shiomi 8-oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts Circulation 104 2001 2883 2885 (Pubitemid 33139097)
12. J. Shite, F. Qin, W. Mao, H. Kawai, S.Y. Stevens, and C. Liang Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy J Am Coll Cardiol 38 2001 1734 1740 (Pubitemid 33065463)
13. M.L. Kukin, J. Kalman, and R.H. Charney Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure Circulation 99 1999 2645 2651 (Pubitemid 29237451)
14. M. Lee, J.L. Saver, W.H. Huang, J. Chow, K.H. Chang, and B. Ovbiagele Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis Circ Cardiovasc Qual Outcomes 3 2010 675 683
15. K. Sahakyan, B.E. Klein, K.E. Lee, M.Y. Tsai, and R. Klein Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus Am J Hypertens 24 2011 59 63
16. S. Wei, L. Zhong, S. Chen, and X. Li The status of coronary artery lesions in patients with conduction disturbance J Cardiovasc Med (Hagerstown) 12 2011 709 713
17. H.S. Park, H. Kim, and J.H. Sohn Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure Korean J Intern Med 25 2010 253 259
18. W.H. Tang, K. Shrestha, and F. Van Lente Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure Am J Cardiol 101 2008 370 373 (Pubitemid 351162964)
19. M. Maurer, S. Burri, and S. de Marchi Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome Int J Cardiol 141 2010 32 38
20. W.H. Tang, F. Van Lente, and K. Shrestha Impact of myocardial function on cystatin C measurements in chronic systolic heart failure J Card Fail 14 2008 394 399 (Pubitemid 351749833)
21. M. Yanavitski, and M.M. Givertz Novel biomarkers in acute heart failure Curr Heart Fail Rep 8 2011 206 211
22. A.P. Burke, R.P. Tracy, and F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies Circulation 105 2002 2019 2023 (Pubitemid 34465262)
23. A.F. Low, S.C. Seow, K.G. Yeoh, Y.T. Lim, H.C. Tan, and T.C. Yeo High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction Ann Acad Med Singapore 33 2004 407 412 (Pubitemid 39280126)
24. L. Risch, A. Blumberg, and A.R. Huber Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates Ren Fail 23 2001 439 448 (Pubitemid 32692279)
25. G. Luc, J.M. Bard, and C. Lesueur Plasma cystatin-C and development of coronary heart disease: the PRIME Study Atherosclerosis 185 2006 375 380
26. T.E. Strandberg Lipid-lowering drugs and heart failure: where do we go after the statin trials? Curr Opin Cardiol 25 2010 385 393
27. S. Miura, and K. Saku Effects of statin and lipoprotein metabolism in heart failure J Cardiol 55 2010 287 290
28. I. Holme, A.H. Aastveit, N. Hammar, I. Jungner, and G. Walldius Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) Eur J Heart Fail 11 2009 1036 1042